Provider review
Vivanta Care review
By The Dose Brief Desk · Updated
Vivanta’s GLP-1 catalog discloses a $75 clinical consultation charge and names DiRx as a pharmacy partner; medication totals require a separate quote.
Not rated. This review examines published program information; it is not a firsthand treatment review.
At a glance
- Semaglutide
- Medication total not verified; $75 consultation is disclosed
- Tirzepatide
- Medication total not verified; $75 consultation is disclosed
- Availability
- Confirm the selected treatment is available in your state.
- Treatment formats
- Compounded semaglutide, tirzepatide and liraglutide; separate B12-combination listings.
The GLP-1 category page says the $75 clinician consultation is charged at checkout. Confirm medication and follow-up charges separately.
A consultation fee comes before a medication total
Vivanta Care’s GLP-1 category page discloses a $75 clinician consultation fee charged at checkout. That is not a complete medication price. Ask whether it is a one-time charge, how follow-up visits are billed and what is refundable if treatment is declined.
The catalog contains different prescriptions
Vivanta lists semaglutide, tirzepatide and liraglutide, plus separate semaglutide/B12 and tirzepatide/B12 products. A clinician is supposed to choose an appropriate option after reviewing the patient’s history. Catalog descriptions about added ingredients should not be taken as proof of a better outcome.
A named pharmacy is a useful starting point
The GLP-1 page identifies DiRx in Fort Lauderdale as a pharmacy partner and explicitly distinguishes compounded preparations from approved brand-name medicines. Confirm whether DiRx will fill your prescription and obtain the formulation, concentration and dispensing instructions.
What a complete quote should answer
Before paying the consultation fee, request medication pricing, included supply, shipping, renewal arrangements and the clinical-denial refund rule. The linked refund page could not be retrieved in this check, so no refund entitlement is assumed. The actual fee and partner disclosure make this program more specific than a generic low-price advertisement.
What stands out
- Consultation fee is explicitly disclosed
- Names DiRx and distinguishes compounded products
What to check
- Medication totals remain unverified
- Consultation refund and renewal rules need confirmation
Sources and review scope
Public information checked in October 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.